126 related articles for article (PubMed ID: 37748633)
1. Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences.
Sharadha M; Vishal Gupta N; Rahamathulla M; Muqtader Ahmed M; Ayesha Farhana S; Osmani RAM; Veeranna B; Koteshwara KB
Int J Pharm; 2023 Nov; 646():123443. PubMed ID: 37748633
[TBL] [Abstract][Full Text] [Related]
2. RETRACTED: Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide.
Kadam RS; Tyagi P; Edelhauser HF; Kompella UB
Int J Pharm; 2012 Sep; 434(1-2):140-7. PubMed ID: 22633904
[TBL] [Abstract][Full Text] [Related]
3. Subconjunctival Delivery of Sorafenib-Tosylate-Loaded Cubosomes for Facilitated Diabetic Retinopathy Treatment: Formulation Development, Evaluation, Pharmacokinetic and Pharmacodynamic (PKPD) Studies.
Madhusudhan S; Gupta NV; Rahamathulla M; Chidambaram SB; Osmani RAM; Ghazwani M; Ahmed MM; Farhana SA; Sarhan MY; Tousif AH
Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896180
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
Chen M; Li X; Liu J; Han Y; Cheng L
J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer-Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy.
Cho H; Kambhampati SP; Lai MJ; Zhou L; Lee G; Xie Y; Hui Q; Kannan RM; Duh EJ
Adv Ther (Weinh); 2021 Feb; 4(2):. PubMed ID: 34527806
[TBL] [Abstract][Full Text] [Related]
6. A non-invasive nanoparticle mediated delivery of triamcinolone acetonide ameliorates diabetic retinopathy in rats.
Mahaling B; Srinivasarao DA; Raghu G; Kasam RK; Bhanuprakash Reddy G; Katti DS
Nanoscale; 2018 Sep; 10(35):16485-16498. PubMed ID: 29897081
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system.
Srinivasarao DA; Sreenivasa Reddy S; Bhanuprakash Reddy G; Katti DS
Int J Pharm; 2021 Oct; 608():121045. PubMed ID: 34481006
[TBL] [Abstract][Full Text] [Related]
8. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
Kambhampati SP; Mishra MK; Mastorakos P; Oh Y; Lutty GA; Kannan RM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):239-49. PubMed ID: 25701805
[TBL] [Abstract][Full Text] [Related]
9. Effect of triamcinolone acetonide on retinal inflammation and angiogenesis induced by pericyte depletion in mouse.
Otsuka T; Masuda T; Takahashi Y; Suzuki A; Uemura A; Arakawa R; Okabe T; Naito A
J Pharmacol Sci; 2023 Jan; 151(1):28-36. PubMed ID: 36522120
[TBL] [Abstract][Full Text] [Related]
10. Triamcinolone Acetonide Suppresses Inflammation and Facilitates Vascular Barrier Function in Human Retinal Microvascular Endothelial Cells.
Imai S; Otsuka T; Naito A; Shimazawa M; Hara H
Curr Neurovasc Res; 2017; 14(3):232-241. PubMed ID: 28625129
[TBL] [Abstract][Full Text] [Related]
11. Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
Srinivasarao DA; Reddy SS; Reddy GB; Katti DS
Int J Pharm; 2019 Sep; 568():118474. PubMed ID: 31279055
[TBL] [Abstract][Full Text] [Related]
12. Chitosan coated nanoparticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration.
Pandit J; Sultana Y; Aqil M
Carbohydr Polym; 2021 Sep; 267():118217. PubMed ID: 34119171
[TBL] [Abstract][Full Text] [Related]
13. The Evolution of Triamcinolone Acetonide Therapeutic Use in Retinal Diseases: From Off-Label Intravitreal Injection to Advanced Nano-Drug Delivery Systems.
Aceves-Franco LA; Sanchez-Aguilar OE; Barragan-Arias AR; Ponce-Gallegos MA; Navarro-Partida J; Santos A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509540
[TBL] [Abstract][Full Text] [Related]
14. Triamcinolone acetonide-chitosan coated liposomes efficiently treated retinal edema as eye drops.
Cheng T; Li J; Cheng Y; Zhang X; Qu Y
Exp Eye Res; 2019 Nov; 188():107805. PubMed ID: 31526807
[TBL] [Abstract][Full Text] [Related]
15. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
[TBL] [Abstract][Full Text] [Related]
16. In Situ Gel of Triamcinolone Acetonide-Loaded Solid Lipid Nanoparticles for Improved Topical Ocular Delivery: Tear Kinetics and Ocular Disposition Studies.
Tatke A; Dudhipala N; Janga KY; Balguri SP; Avula B; Jablonski MM; Majumdar S
Nanomaterials (Basel); 2018 Dec; 9(1):. PubMed ID: 30591688
[TBL] [Abstract][Full Text] [Related]
17. Characterization and Pharmacokinetics of Triamcinolone Acetonide-Loaded Liposomes Topical Formulations for Vitreoretinal Drug Delivery.
Altamirano-Vallejo JC; Navarro-Partida J; Gonzalez-De la Rosa A; Hsiao JH; Olguín-Gutierrez JS; Gonzalez-Villegas AC; Keller BC; Bouzo-Lopez L; Santos A
J Ocul Pharmacol Ther; 2018 Jun; 34(5):416-425. PubMed ID: 29584529
[TBL] [Abstract][Full Text] [Related]
18. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
19. Development of Triamcinolone Acetonide Nanocrystals for Ocular Administration.
Formica ML; Awde Alfonso HG; Paredes AJ; Melian ME; Camacho NM; Faccio R; Tártara LI; Palma SD
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36840006
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of triamcinolone acetonide on corneal neovascularization.
Murata M; Shimizu S; Horiuchi S; Taira M
Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):205-9. PubMed ID: 16044325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
